HBT
GSK icon

Hills Bank & Trust’s GSK GSK Stock Holding History

Hills Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Sell
17,496
-2,643
-13% -$140K 0.04% 184
2026
Q1 		$1.11M Sell
20,139
-8,561
-30% -$464K 0.05% 153
2025
Q4 		$1.41M Sell
28,700
-3,055
-10% -$142K 0.08% 124
2025
Q3 		$1.37M Buy
31,755
+1,435
+5% +$56.1K 0.08% 131
2025
Q2 		$1.16M Buy
30,320
+2,402
+9% +$91.8K 0.07% 138
2025
Q1 		$1.08M Buy
27,918
+1,234
+5% +$45.2K 0.08% 134
2024
Q4 		$902K Buy
26,684
+1,386
+5% +$49.9K 0.07% 146
2024
Q3 		$1.03M Sell
25,298
-1,131
-4% -$46.3K 0.08% 140
2024
Q2 		$1.02M Buy
26,429
+2,954
+13% +$124K 0.08% 135
2024
Q1 		$1.01M Buy
23,475
+2,191
+10% +$90.4K 0.09% 134
2023
Q4 		$789K Buy
21,284
+1,429
+7% +$51.3K 0.08% 138
2023
Q3 		$720K Buy
19,855
+2,092
+12% +$74.3K 0.08% 131
2023
Q2 		$633K Buy
17,763
+2,709
+18% +$97.2K 0.08% 128
2023
Q1 		$536K Buy
15,054
+7,249
+93% +$254K 0.07% 137
2022
Q4 		$274K Buy
+7,805
New +$260K 0.04% 178

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Hills Bank & Trust's GSK Position: Q2 2026 in Review

Hills Bank & Trust reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $140K and leaving 17,496 shares worth $917K. The position accounts for 0.04% of the portfolio, ranked #184.

Hills Bank & Trust first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.41M in Q4 2025. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Hills Bank & Trust held 17,496 shares of GSK worth $917K as of Q2 2026.
  • Hills Bank & Trust sold 2,643 GSK shares in Q2 2026, an estimated $140K.
  • GSK made up 0.04% of Hills Bank & Trust's portfolio in Q2 2026, its #184 holding.
  • Hills Bank & Trust first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • Hills Bank & Trust's GSK position peaked at $1.41M in Q4 2025.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Hills Bank & Trust's 13F filing for Q2 2026, filed 10 Aug 2026.